Bion Therapeutics (India) Profile
Key Indicators
- Authorised Capital ₹ 0.60 M
as on 17-07-2024
- Paid Up Capital ₹ 0.60 M
as on 17-07-2024
- Company Age 19 Year, 3 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 7.76 Cr
as on 17-07-2024
- Satisfied Charges ₹ 7.85 Cr
as on 17-07-2024
- Revenue 44.86%
(FY 2022)
- Profit 8.49%
(FY 2022)
- Ebitda 41.94%
(FY 2022)
- Net Worth 51.24%
(FY 2022)
- Total Assets 139.36%
(FY 2022)
About Bion Therapeutics (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.60 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹7.76 Cr. The company has closed loans amounting to ₹7.85 Cr, as per Ministry of Corporate Affairs (MCA) records.
Laxman Prasad, Beerelli Satyam, Sudesh Mathur, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24239TG2005PTC047358
- Company No.
047358
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Sep 2005
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Bion Therapeutics (India) Private Limited offer?
Bion Therapeutics (India) Private Limited offers a wide range of products and services, including Health Conditions, Pain Relief, Bone, Joint & Muscle Care, Heart Care.
Who are the key members and board of directors at Bion Therapeutics (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Laxman Prasad  | Managing Director | 05-Sep-2005 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Beerelli Satyam | Director | 05-Sep-2005 | Current |
| Sudesh Mathur | Director | 05-Sep-2005 | Current |
| Giridhara Mungi | Director | 09-Nov-2015 | Current |
| Amitav Rout | Director | 26-Jul-2019 | Current |
Financial Performance of Bion Therapeutics (India).
Bion Therapeutics (India) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 44.86% increase. The company also saw a slight improvement in profitability, with a 8.49% increase in profit. The company's net worth Soared by an impressive increase of 51.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bion Therapeutics (India)?
In 2022, Bion Therapeutics (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Lakshya Lifescience Private LimitedActive 3 years 3 monthsLaxman Prasad and Amitav Rout are mutual person
- Biondia Therapeutics Private LimitedActive 14 years 7 months
Laxman Prasad and Beerelli Satyam are mutual person
- Health Essentials (India) Private LimitedActive 9 years 7 months
Laxman Prasad and Giridhara Mungi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 Jul 2023 | ₹1.00 Cr | Open |
Axis Bank Limited Creation Date: 19 Jul 2023 | ₹6.76 Cr | Open |
Indian Overseas Bank Creation Date: 31 Dec 2021 | ₹6.10 Cr | Satisfied |
How Many Employees Work at Bion Therapeutics (India)?
Bion Therapeutics (India) has a workforce of 172 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bion Therapeutics (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bion Therapeutics (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
